Rouslan Kotchetkov

2.5k total citations · 1 hit paper
47 papers, 2.0k citations indexed

About

Rouslan Kotchetkov is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Rouslan Kotchetkov has authored 47 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Oncology and 12 papers in Hematology. Recurrent topics in Rouslan Kotchetkov's work include Neuroblastoma Research and Treatments (8 papers), Lymphoma Diagnosis and Treatment (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Rouslan Kotchetkov is often cited by papers focused on Neuroblastoma Research and Treatments (8 papers), Lymphoma Diagnosis and Treatment (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Rouslan Kotchetkov collaborates with scholars based in Canada, Germany and United States. Rouslan Kotchetkov's co-authors include Jindřich Činátl, Joyce M. Slingerland, Jens‐Uwe Vogel, Michael K. Connor, Richard Beniston, Jaroslav Činátl, Jin Hwa Lee, Kathy Han, Jiyong Liang and Charles Catzavelos and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Rouslan Kotchetkov

44 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest

2002 757 citations Jiyong Liang, Teresa Petrocelli et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rouslan Kotchetkov Canada	19	1.3k	867	330	261	208	47	2.0k
Maria Zajac‐Kaye United States	28	1.2k 0.9×	833 1.0×	209 0.6×	158 0.6×	276 1.3×	65	1.9k
Toshiki Mori Japan	16	1.6k 1.3×	868 1.0×	159 0.5×	189 0.7×	301 1.4×	24	2.4k
Daitoku Sakamuro United States	24	1.5k 1.2×	822 0.9×	377 1.1×	217 0.8×	253 1.2×	39	2.4k
Daniel S. Wechsler United States	23	833 0.7×	275 0.3×	275 0.8×	249 1.0×	232 1.1×	66	1.8k
José Grenet United States	19	1.5k 1.2×	674 0.8×	165 0.5×	278 1.1×	394 1.9×	26	1.9k
Fumihiko Okumura Japan	21	1.7k 1.4×	682 0.8×	181 0.5×	509 2.0×	255 1.2×	36	2.2k
Christian Touriol France	30	1.8k 1.4×	424 0.5×	204 0.6×	228 0.9×	389 1.9×	46	2.5k
Grzegorz Nalepa United States	21	2.0k 1.6×	724 0.8×	264 0.8×	144 0.6×	285 1.4×	42	2.5k
Alan W. Lau United States	19	1.5k 1.2×	638 0.7×	169 0.5×	165 0.6×	211 1.0×	20	2.1k
Venkateshwar A. Reddy United States	17	1.4k 1.1×	807 0.9×	206 0.6×	335 1.3×	289 1.4×	29	2.1k

Countries citing papers authored by Rouslan Kotchetkov

Since Specialization

Citations

This map shows the geographic impact of Rouslan Kotchetkov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rouslan Kotchetkov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rouslan Kotchetkov more than expected).

Fields of papers citing papers by Rouslan Kotchetkov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rouslan Kotchetkov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rouslan Kotchetkov. The network helps show where Rouslan Kotchetkov may publish in the future.

Co-authorship network of co-authors of Rouslan Kotchetkov

This figure shows the co-authorship network connecting the top 25 collaborators of Rouslan Kotchetkov. A scholar is included among the top collaborators of Rouslan Kotchetkov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rouslan Kotchetkov. Rouslan Kotchetkov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kotchetkov, Rouslan, et al.. (2025). Progressive Multifocal Leukoencephalopathy after Administration of Front-Line Obinutuzumab and Venetoclax in a Patient with Chronic Lymphocytic Leukemia: Case Report. Case Reports in Oncology. 18(1). 1602–1610.

Kotchetkov, Rouslan, et al.. (2024). Case report: Peri-procedural hydroxyurea helps minimize bleeding in patients with Essential Thrombocythemia associated with acquired von Willebrand syndrome. Frontiers in Oncology. 14. 1326209–1326209. 1 indexed citations

Kotchetkov, Rouslan, et al.. (2024). Isolated Non-Secretory Extramedullary Relapse of Multiple Myeloma Responded Completely to Localized Radiotherapy. SHILAP Revista de lepidopterología. 17(1). 423–429.

Kotchetkov, Rouslan, et al.. (2023). Case Report: Effects of multiple myeloma therapy on essential thrombocythemia and vice versa: a case of synchronous dual hematological malignancy. Frontiers in Oncology. 13. 1213942–1213942. 1 indexed citations

Kotchetkov, Rouslan, et al.. (2021). Lymphocytosis with Smudge Cells Is Not Equivalent to Chronic Lymphocytic Leukemia. Case Reports in Oncology. 14(2). 950–956. 1 indexed citations

Kotchetkov, Rouslan, et al.. (2020). Premedication with montelukast and rupatadine decreased rituximab infusion time, rate, severity of reactions and use of rescue medications. International Journal of Cancer. 147(7). 1979–1986. 7 indexed citations

Kotchetkov, Rouslan, et al.. (2018). Leukoerythroblastosis with Cytopenia as an Initial Presentation of Lung Adenocarcinoma. Case Reports in Oncology. 11(2). 567–572. 1 indexed citations

Michelis, Fotios V., Rouslan Kotchetkov, Eshetu G. Atenafu, et al.. (2017). Long-Term Incidence of Secondary Malignancies after Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience. Biology of Blood and Marrow Transplantation. 23(6). 945–951. 8 indexed citations

Kotchetkov, Rouslan & Erin Ellison. (2014). Metastatic lobular breast carcinoma mimicking multiple myeloma. Blood. 124(14). 2313–2313. 5 indexed citations

10.

Michaelis, Martin, Jaroslav Činátl, Jaroslav Činátl, et al.. (2006). Onconase induces caspase-independent cell death in chemoresistant neuroblastoma cells. Cancer Letters. 250(1). 107–116. 41 indexed citations

11.

Blaheta, Roman A., Martin Michaelis, Dietger Jonas, et al.. (2006). Chemoresistance induces enhanced adhesion and transendothelial penetration of neuroblastoma cells by down-regulating NCAM surface expression. BMC Cancer. 6(1). 294–294. 32 indexed citations

12.

Koehl, Ulrike, R. Esser, Stefanie Zimmermann, et al.. (2005). Ex vivo Expansion of Highly Purified NK Cells for Immunotherapy after Haploidentical Stem Cell Transplantation in Children. Klinische Pädiatrie. 217(6). 345–350. 79 indexed citations

13.

Michaelis, Martin, Uwe Michaelis, Ingrid Fleming, et al.. (2004). Valproic Acid Inhibits Angiogenesis in Vitro and in Vivo. Molecular Pharmacology. 65(3). 520–527. 188 indexed citations

14.

Connor, Michael K., Rouslan Kotchetkov, Richard Beniston, et al.. (2003). CRM1/Ran-Mediated Nuclear Export of p27^Kip1Involves a Nuclear Export Signal and Links p27 Export and Proteolysis. Molecular Biology of the Cell. 14(1). 201–213. 157 indexed citations

15.

Činátl, Jindřich, Martin Scholz, Rouslan Kotchetkov, Jens‐Uwe Vogel, & Hans Wilhelm Doerr. (2003). Molecular mechanisms of the modulatory effects of HCMV infection in tumor cell biology. Trends in Molecular Medicine. 10(1). 19–23. 70 indexed citations

16.

Činátl, Jindřich, Rouslan Kotchetkov, Roman A. Blaheta, et al.. (2002). Induction of differentiation and suppression of malignant phenotype of human neuroblastoma BE(2)-C cells by valproic acid: Enhancement by combination with interferon-α. International Journal of Oncology. 78 indexed citations

17.

Liang, Jiyong, Teresa Petrocelli, Rouslan Kotchetkov, et al.. (2002). PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nature Medicine. 8(10). 1153–1160. 757 indexed citations breakdown →

18.

Kotchetkov, Rouslan, et al.. (2000). Antineoplastic activity of a novel multimeric gemcitabine-monophosphate prodrug against thyroid cancer cells in vitro.. PubMed. 20(5A). 2915–22. 8 indexed citations

19.

Kotchetkov, Rouslan, et al.. (1999). Selective cytotoxic activity of a novel ribonucleoside diphosphate reductase inhibitor MDL-101,731 against thyroid cancer in vitro.. PubMed. 45(5). 185–91. 4 indexed citations

20.

Činátl, Jindřich, et al.. (1999). Proinflammatory Potential of Cytomegalovirus Infection. Intervirology. 42(5-6). 419–424. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact